Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Masatoshi Kudo | Researchclopedia

Back to researchers

Masatoshi Kudo

Kindai University ORCID

2,827

Works

124,899

Citations

143

h-index

1051

i10-index

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Pancreatic and Hepatic Oncology Research

Affiliations

Kanazawa University2009–2009

Nihon University2000–2000

Kurume University2003–2007

University of Delhi2006–2006

Hiroshima University2019–2019

Top Works

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn,Shukui Qin,et al.

20206,928 citations

Cancer Immunotherapy and Biomarkers

Colorectal Cancer Treatments and Studies

A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.

20175,940 citations

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo,Richard S. Finn,et al.

20185,313 citations

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry,Bruno Sangro,et al.

20174,261 citations

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Jordi Bruix,Shukui Qin,et al.

20163,613 citations

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Andrew X. Zhu,Richard S. Finn,et al.

20182,498 citations

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata,Ann‐Lii Cheng,et al.

20172,137 citations

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

Richard S. Finn,Baek‐Yeol Ryoo,et al.

20191,783 citations

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu,Yoon‐Koo Kang,et al.

20191,632 citations